Cetyl Myristoleate (CMO) vs DIM (Diindolylmethane)

Mechanism

Fatty acid ester with anti-inflammatory and joint-lubricating properties. Modulates immune response by inhibiting 5-lipoxygenase and modulating prostaglandin synthesis. Reduces joint inflammation and improves range of motion in arthritic conditions.

Contraindications

• Severe liver disease

Mechanism

DIM is formed from indole-3-carbinol (I3C, from cruciferous vegetables) via acid condensation in the stomach. It modulates estrogen metabolism by promoting the 2-hydroxylation pathway (producing 2-hydroxyestrone, considered 'protective' estrogen) over the 16alpha-hydroxylation pathway (producing 16alpha-hydroxyestrone, considered proliferative) and the 4-hydroxylation pathway (producing 4-hydroxyestrone, genotoxic). DIM binds the aryl hydrocarbon receptor (AhR), inducing Phase I (CYP1A1, CYP1A2) and Phase II enzymes that facilitate estrogen detoxification. It also inhibits aromatase and has anti-androgen receptor effects (competitive binding).

Standard Dosing

100-200mg DIM daily

Timing

With meals (fat enhances absorption). Consistent daily dosing for estrogen metabolism modulation.

Cycle Duration

ongoing or cycle 8-12 weeks on, 4 weeks off

Side Effects

• Harmless dark-colored urine
• GI upset
• Headache
• Changes in menstrual cycle
• Potential anti-androgenic effects at high doses in men

Contraindications

• Estrogen-dependent conditions where estrogen reduction is not desired
• Concurrent tamoxifen/AI therapy (without oncologist approval)
• Pregnancy/lactation

Best Stacking Partners